Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review

• Main Authors: Miguel Mansilla-Polo (Author), Daniel Morgado-Carrasco (Author)
• Formato: Livro
• Publicado em: Adis, Springer Healthcare, 2024-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Introduction The risk of infections associated with biological drugs (BD) and Janus kinase inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth of studies that evaluate both pharmacological groups together and, furthermore, compare them. Here, we rev...